{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:51:28Z","timestamp":1779234688523,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics and Cytogenetics"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.cancergencyto.2008.01.005","type":"journal-article","created":{"date-parts":[[2008,4,13]],"date-time":"2008-04-13T12:15:53Z","timestamp":1208088953000},"page":"95-102","source":"Crossref","is-referenced-by-count":34,"title":["Mechanisms of genesis of variant translocation in chronic myeloid leukemia are not correlated with ABL1 or BCR deletion status or response to imatinib therapy"],"prefix":"10.1016","volume":"182","author":[{"given":"Steven","family":"Richebourg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginie","family":"Eclache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Perot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-France","family":"Portnoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Van den Akker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Terr\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odile","family":"Maareck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Soenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Vigui\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Luc","family":"La\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"Andrieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9lim","family":"Corm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Roche-Lestienne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergencyto.2008.01.005_bib1","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199907153410306","article-title":"The biology of chronic myeloid leukemia","volume":"34","author":"Faderl","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib2","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/315550a0","article-title":"Fused transcript of abl and bcr genes in chronic myelogenous leukaemia","volume":"315","author":"Shtivelman","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF00193575","article-title":"Complex translocations, simple variant translocations and Ph-negative cases in chronic myelogenous leukaemia","volume":"85","author":"Huret","year":"1990","journal-title":"Hum Genet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cancergencyto.2005.11.017","article-title":"Complex chromosomal rearrangements in patients with chronic myeloid leukemia","volume":"168","author":"Babicka","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0165-4608(91)90145-K","article-title":"Complex chromosomal translocations in the Philadelphia chromosome leukemias: serial translocations or a concerted genomic rearrangement?","volume":"57","author":"Fitzgerald","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2141.2003.04291.x","article-title":"Survival implications of molecular heterogeneity in variant Philadelphia-positive chronic myeloid leukaemia","volume":"121","author":"Reid","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0165-4608(03)00128-6","article-title":"Genesis of variant Philadelphia chromosome translocations in chronic myelocytic leukemia","volume":"147","author":"Naumann","year":"2003","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cancergencyto.2006.10.006","article-title":"On the genesis and prognosis of variant translocations in chronic myeloid leukemia","volume":"173","author":"Gorusu","year":"2007","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1182\/blood.V95.3.738.003k21_738_743","article-title":"Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia","volume":"95","author":"Sinclair","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib10","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1182\/blood.V98.6.1732","article-title":"Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia","volume":"98","author":"Huntly","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/gcc.10116","article-title":"Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients","volume":"35","author":"Storlazzi","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/10428190310001623900","article-title":"Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes","volume":"45","author":"Specchia","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib13","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1182\/blood.V97.11.3581","article-title":"Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis","volume":"97","author":"Kolomietz","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib14","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1080\/1042819031000097384","article-title":"Deletion of the 5\u2032ABL region in Philadelphia chromosome positive chronic myeloid leukemia: frequency, origin and prognosis","volume":"44","author":"Morel","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cancergencyto.2005.01.002","article-title":"Deletions of the 3\u2032BCR and 5\u2032ABL regions in patients with Philadelphia-positive chronic myeloid leukemia: a one-step process occurring in about 10% of the cases without any evidence of genetic instability in the target cells","volume":"160","author":"Fournier","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/gcc.10197","article-title":"A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression","volume":"37","author":"Lee","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib17","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1399-0004.2005.00521.x","article-title":"Evidence for deletion of 9q as a two-step process in chronic myeloid leukemia","volume":"68","author":"Rudduck-Sivaswaren","year":"2005","journal-title":"Clin Genet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib18","article-title":"ISCN 1995: an international system for human cytogenetic nomenclature (1995)","year":"1995"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib19","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2006-02-005686","article-title":"Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"108","author":"Baccarani","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib20","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-4608(91)90248-S","article-title":"Complex Ph translocations in chronic myeloid leukemia","volume":"55","author":"Fitzgerald","year":"1991","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib21","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2141.1994.tb04933.x","article-title":"Philadelphia-negative chronic myeloid leukaemia: detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or chromosome 22","volume":"87","author":"Nacheva","year":"1994","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0165-4608(88)90314-7","article-title":"The Philadelphia chromosome: considerations based on studies of variant Ph translocations","volume":"32","author":"Ishihara","year":"1988","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hon.775","article-title":"Generation of the BCR\/ABL fusion gene in a Philadelphia chromosome-negative chronic myeloid leukaemia: insertion of 5.6 Mb of 9q34 into the BCR region of chromosome 22","volume":"24","author":"Valle","year":"2006","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0165-4608(99)00187-9","article-title":"A FISH study of variant Philadelphia rearrangements","volume":"118","author":"Reddy","year":"2000","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib25","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-4608(81)90017-0","article-title":"Unusual translocation and chronic myelocytic leukemia: \u201cmasked\u201d Philadelphia chromosome (Ph 1)","volume":"4","author":"Lessard","year":"1981","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/gcc.20161","article-title":"Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH","volume":"43","author":"Kim","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/gcc.20163","article-title":"Genesis of derivative chromosome 9 deletions in chronic myeloid leukemia","volume":"43","author":"Reid","year":"2005","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cancergencyto.2004.02.012","article-title":"Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis","volume":"154","author":"Aoun","year":"2004","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergencyto.2008.01.005_bib29","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0165-4608(99)00067-9","article-title":"Clinical implications of fluorescence in situ hybridization analysis in 13 chronic myeloid leukemia cases: Ph-negative and variant Ph-positive","volume":"114","author":"Yehuda","year":"1999","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Cancer Genetics and Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165460808000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T07:52:56Z","timestamp":1588578776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165460808000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0165460808000277"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergencyto.2008.01.005","relation":{},"ISSN":["0165-4608"],"issn-type":[{"value":"0165-4608","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}